ATE399156T1 - Neue indol- oder benzimidazol-derivate - Google Patents

Neue indol- oder benzimidazol-derivate

Info

Publication number: ATE399156T1
Authority: AT; Austria
Prior art keywords: compounds; benzimidazole derivatives; new indole; pharmaceutically acceptable; acceptable salts
Prior art date: 2004-10-27

Application number

AT05806665T

Other languages

English (en)

Inventor

Konrad Bleicher

Matthias Nettekoven

Philippe Pflieger

Stephan Roever

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-27

Filing date

2005-10-18

Publication date

2008-07-15

2005-10-18 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2008-07-15 Application granted granted Critical

2008-07-15 Publication of ATE399156T1 publication Critical patent/ATE399156T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Psychiatry (AREA)
Addiction (AREA)
Endocrinology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Pulmonology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychology (AREA)
Oncology (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Rheumatology (AREA)
Nutrition Science (AREA)
Otolaryngology (AREA)
Vascular Medicine (AREA)
Gynecology & Obstetrics (AREA)

AT05806665T 2004-10-27 2005-10-18 Neue indol- oder benzimidazol-derivate ATE399156T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP04105329		2004-10-27

Publications (1)

Publication Number	Publication Date
ATE399156T1 true ATE399156T1 (de)	2008-07-15

Family

ID=35658930

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05806665T ATE399156T1 (de)	2004-10-27	2005-10-18	Neue indol- oder benzimidazol-derivate

Country Status (14)

Country	Link
US (2)	US7384945B2 (de)
EP (1)	EP1807398B1 (de)
JP (1)	JP2008517959A (de)
KR (1)	KR100912146B1 (de)
CN (1)	CN101048382B (de)
AT (1)	ATE399156T1 (de)
AU (1)	AU2005298986A1 (de)
BR (1)	BRPI0517369A (de)
CA (1)	CA2585030A1 (de)
DE (1)	DE602005007765D1 (de)
ES (1)	ES2309812T3 (de)
MX (1)	MX2007004910A (de)
RU (1)	RU2394027C2 (de)
WO (1)	WO2006045478A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE526963T1 (de) *	2006-05-04	2011-10-15	Lek Pharmaceuticals	Pharmazeutische zusammensetzung mit olmesartan- medoxomil
US9051265B2 (en)	2011-06-06	2015-06-09	The Scripps Research Institute	N-benzylindole modulators of PPARG
US8957093B2 (en)	2011-06-06	2015-02-17	The Scripps Research Institute	N-biphenylmethylindole modulators of PPARG
WO2013078240A1 (en)	2011-11-22	2013-05-30	Ripka Amy S	N-biphenylmethylbenzimidazole modulators of pparg
US8685959B2 (en) *	2011-12-01	2014-04-01	Chemocentryx, Inc.	Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
EP2785692B1 (de) *	2011-12-01	2017-09-27	ChemoCentryx, Inc.	Substituierte aniline als ccr(4)-antagonisten
CA2860382C (en)	2011-12-21	2017-09-12	Allergan, Inc.	Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response
EA028626B1 (ru)	2012-06-11	2017-12-29	Юсб Байофарма Спрл	БЕНЗИМИДАЗОЛЫ, МОДУЛИРУЮЩИЕ TNF-α
WO2015161108A1 (en)	2014-04-16	2015-10-22	The Scripps Research Institute	Pparg modulators for treatment of osteoporosis
WO2017035114A1 (en) *	2015-08-25	2017-03-02	Janssen Pharmaceutica Nv	Benzimidazole derivatives useful as cb-1 inverse agonists

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3940418A (en)	1972-04-07	1976-02-24	G. D. Searle & Co.	Esters and amides of 4,5-dihydrobenz[g]indazole-3-carboxylic acids and related compounds
FR2692575B1 (fr)	1992-06-23	1995-06-30	Sanofi Elf	Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2713225B1 (fr)	1993-12-02	1996-03-01	Sanofi Sa	N-pipéridino-3-pyrazolecarboxamide substitué.
FR2714057B1 (fr)	1993-12-17	1996-03-08	Sanofi Elf	Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
US5596106A (en)	1994-07-15	1997-01-21	Eli Lilly And Company	Cannabinoid receptor antagonists
JPH10508321A (ja) *	1995-09-01	1998-08-18	イーライ・リリー・アンド・カンパニー	インドリル神経ペプチドｙレセプターアンタゴニスト
FR2741621B1 (fr)	1995-11-23	1998-02-13	Sanofi Sa	Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant
US6166219A (en) *	1995-12-28	2000-12-26	Fujisawa Pharmaceutical Co., Ltd.	Benzimidazole derivatives
KR20010041346A (ko) *	1998-02-25	2001-05-15	브루스 엠. 에이센, 토마스 제이 데스로저	포스포리파제 ａ2 억제제
EP1056719A2 (de) *	1998-02-25	2000-12-06	Genetics Institute, Inc.	Inhibitoren von phospholipasen enzymen
IL141769A0 (en)	1998-09-11	2002-03-10	Aventis Pharma Sa	Azetidine derivatives, preparation and medicines containing them
FR2783246B1 (fr)	1998-09-11	2000-11-17	Aventis Pharma Sa	Derives d'azetidine, leur preparation et les medicaments les contenant
FR2789079B3 (fr)	1999-02-01	2001-03-02	Sanofi Synthelabo	Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
GB9919411D0 (en) *	1999-08-18	1999-10-20	Zeneca Ltd	Chemical compounds
FR2800375B1 (fr)	1999-11-03	2004-07-23	Sanofi Synthelabo	Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant
FR2805810B1 (fr)	2000-03-03	2002-04-26	Aventis Pharma Sa	Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation
US6355631B1 (en)	2000-03-03	2002-03-12	Aventis Pharma S.A.	Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
US6566356B2 (en)	2000-03-03	2003-05-20	Aventis Pharma S.A.	Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
FR2805817B1 (fr)	2000-03-03	2002-04-26	Aventis Pharma Sa	Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
FR2805818B1 (fr)	2000-03-03	2002-04-26	Aventis Pharma Sa	Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
US6479479B2 (en)	2000-03-03	2002-11-12	Aventis Pharma S.A.	Azetidine derivatives, their preparation and pharmaceutical compositions containing them
PT1268435E (pt)	2000-03-23	2007-02-28	Solvay Pharm Bv	Derivados de 4,5-diidro-1h-pirazol tendo actividade cb1-antagonista
FR2814678B1 (fr)	2000-10-04	2002-12-20	Aventis Pharma Sa	Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite
SE0101387D0 (sv) *	2001-04-20	2001-04-20	Astrazeneca Ab	Novel compounds
WO2003005393A1 (de) *	2001-06-29	2003-01-16	Siemens Aktiengesellschaft	Vakuumschaltröhre für hohe kurzschlussströme
WO2003053938A1 (en) *	2001-12-20	2003-07-03	Novo Nordisk A/S	Benzimidazols and indols as glucagon receptor antagonists/inverse agonisten
EP1787982B1 (de) *	2003-04-11	2010-05-12	High Point Pharmaceuticals, LLC	Verbindungen mit Aktivität an der 11Beta-Hydroxasteroiddehydrogenase
SE0301701D0 (sv) *	2003-06-10	2003-06-10	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof

2005
- 2005-10-18 AU AU2005298986A patent/AU2005298986A1/en not_active Abandoned
- 2005-10-18 KR KR1020077011823A patent/KR100912146B1/ko not_active IP Right Cessation
- 2005-10-18 CA CA002585030A patent/CA2585030A1/en not_active Abandoned
- 2005-10-18 AT AT05806665T patent/ATE399156T1/de active
- 2005-10-18 EP EP05806665A patent/EP1807398B1/de not_active Not-in-force
- 2005-10-18 CN CN2005800366958A patent/CN101048382B/zh not_active Expired - Fee Related
- 2005-10-18 DE DE602005007765T patent/DE602005007765D1/de active Active
- 2005-10-18 JP JP2007538299A patent/JP2008517959A/ja not_active Ceased
- 2005-10-18 RU RU2007119638/04A patent/RU2394027C2/ru not_active IP Right Cessation
- 2005-10-18 WO PCT/EP2005/011176 patent/WO2006045478A1/en active IP Right Grant
- 2005-10-18 BR BRPI0517369-8A patent/BRPI0517369A/pt not_active IP Right Cessation
- 2005-10-18 MX MX2007004910A patent/MX2007004910A/es active IP Right Grant
- 2005-10-18 ES ES05806665T patent/ES2309812T3/es active Active
- 2005-10-25 US US11/257,885 patent/US7384945B2/en not_active Expired - Fee Related
2008
- 2008-05-02 US US12/114,219 patent/US7786128B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
BRPI0517369A (pt)	2008-10-07
US20060089367A1 (en)	2006-04-27
ES2309812T3 (es)	2008-12-16
RU2394027C2 (ru)	2010-07-10
CN101048382B (zh)	2010-05-05
EP1807398B1 (de)	2008-06-25
MX2007004910A (es)	2007-06-14
US7786128B2 (en)	2010-08-31
EP1807398A1 (de)	2007-07-18
US20080234290A1 (en)	2008-09-25
CN101048382A (zh)	2007-10-03
JP2008517959A (ja)	2008-05-29
RU2007119638A (ru)	2008-12-10
DE602005007765D1 (de)	2008-08-07
CA2585030A1 (en)	2006-05-04
WO2006045478A1 (en)	2006-05-04
AU2005298986A1 (en)	2006-05-04
KR20070084545A (ko)	2007-08-24
KR100912146B1 (ko)	2009-08-14
US7384945B2 (en)	2008-06-10

Publication	Publication Date	Title
EA200870193A1 (ru)	2009-02-27	Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
ATE517882T1 (de)	2011-08-15	Chinolinderivate
ATE430744T1 (de)	2009-05-15	Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
RS52823B (en)	2013-10-31	NEW UNITS USEFUL FOR TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
EA201491607A1 (ru)	2015-07-30	Модуляторы толлподобных рецепторов
ATE496620T1 (de)	2011-02-15	1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren
EP2178869A4 (de)	2012-03-21	Indolverbindungen als hemmer von zellnekrose
ATE449776T1 (de)	2009-12-15	Pyrroloä2,3-cüpyridinderivate
WO2008048981A3 (en)	2008-09-18	Indole antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
MX2008013196A (es)	2008-10-22	5-amido-2-carboxiamida-indoles.
MX2009003316A (es)	2009-04-09	Derivados de pirazina-2-carboxamida como moduladores receptores de cb2.
ATE467632T1 (de)	2010-05-15	Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors
ATE384058T1 (de)	2008-02-15	Thiazolderivate
TW200736233A (en)	2007-10-01	Cyclohexyl piperazinyl methanone derivatives
NO20082096L (no)	2008-05-29	Azaindol-2-karboksamidderivativer
TW200612936A (en)	2006-05-01	Indole derivatives
TW200637817A (en)	2006-11-01	5-aminoindole derivatives
TW200738651A (en)	2007-10-16	Cyclohexyl sulfonamide derivatives
ATE492534T1 (de)	2011-01-15	1h-indol-5-ylpiperazin-1-ylmethanonderivate
ATE478856T1 (de)	2010-09-15	Spirobenzodioxole und deren verwendung als cb1- antagonisten
DE602006014022D1 (de)	2010-06-10	5-substituierte indol-2-carbonsäureamidderivate
TW200626158A (en)	2006-08-01	Naphthaline derivatives
ATE466842T1 (de)	2010-05-15	3-substituierte pyridinderivate als h3- antagonisten
ATE399156T1 (de)	2008-07-15	Neue indol- oder benzimidazol-derivate
MY157425A (en)	2016-06-15	Substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses

Legal Events

Date	Code	Title	Description
2009-01-15	UEP	Publication of translation of european patent specification	Ref document number: 1807398 Country of ref document: EP

Date

Code

Title

Description

2009-01-15

UEP

Publication of translation of european patent specification

Ref document number: 1807398

Country of ref document: EP